/Companies

Frontier Medicines

South San Francisco, US · Founded 2018 · Delaware corporation · 81 employees on LinkedIn · 12 known investors

Find your way into Frontier Medicines

Sign up to see every warm intro you have to Frontier Medicines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Frontier Medicines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.

Founders & leadership

Frontier Medicines was founded in 2018 by Chris Varma, Ph.D. and Chris Varma.

CVChris Varma, Ph.D.
Chris Varma, Ph.D.Co-founderManaging Partner at MPM BioImpact
CVChris Varma
Chris VarmaCo-founder, Chairman and CEOChris Varma co-founded Blueprint Medicines (acquired by Sanofi) and Warp Drive Bio (acquired by Revolution Medicines), and has held senior roles at venture capital firms Flagship Pioneering, Third Rock Ventures, and MPM Capital. He holds a Ph.D. from Harvard-MIT's HST program in machine learning and cancer biology, as well as advanced degrees in computer science and management from Stanford.
JW
Jim WinklerExecutive
JHJohannes Hermann, Ph.D.
Johannes Hermann, Ph.D.Executive
KWKevin Webster
Kevin WebsterChief Science Officer
GC
Gregory ChowExecutive

Board

JNJanwillem Naesens
Janwillem NaesensBoard directorManaging Partner at Droia Ventures
CWCameron Wheeler
Cameron WheelerBoard directorPartner at Deerfield Management Company
LELuke Evnin
Luke EvninBoard directorAdvisor at MPM BioImpact
OLOthman Laraki
Othman LarakiBoard MemberExecutive Officer, Director at Color Genomics

Investors · 12

Also in the syndicate · 3

DeerfieldGalapagosGalapagos NV

Funding

SEC filings, press & company announcements

$235.5M disclosed across 3 of 5 rounds · 2019–2025

▶$88.5MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim WinklerExecutive Officer
  • Janwillem NaesensDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Kevin WebsterExecutive Officer
  • Cameron WheelerDirector
  • Luke EvninDirector
  • Gregory ChowExecutive Officer
  • Chris Varma, Ph.D.Executive Officer, Director
  • Othman LarakiDirector
Offering amount
$88.5M
Amount sold
$88.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$67MraisedNov 2020 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris Varma, Ph.D.Executive Officer, Director
  • Luke EvninDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Othman LarakiDirector
  • Janwillem NaesensDirector
  • Cameron WheelerDirector
  • Jim WinklerExecutive Officer
  • Kevin WebsterExecutive Officer
Offering amount
$67M
Amount sold
$67M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Frontier Medicines went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Frontier Medicines.

In the news

Frequently asked questions

What does Frontier Medicines do?
Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.
Who founded Frontier Medicines?
Frontier Medicines was founded by Chris Varma, Ph.D., Chris Varma in 2018.
Who are Frontier Medicines's investors?
Frontier Medicines's investors include Berkeley Catalyst, DCVC (Data Collective), Droia Ventures, Felicis Ventures, MPM BioImpact, RA Capital, DCVC Bio, Deerfield Management Company and 1 more.
How much funding has Frontier Medicines raised?
Frontier Medicines has disclosed $235.5M raised across 3 of its 5 known rounds.
Where is Frontier Medicines headquartered?
Frontier Medicines is headquartered in South San Francisco, US.